XNYS 14 Jul, 2025 4:12 PM (EDT)
| Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|
| Robert A. Demichiei | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Apr 2025 | 10,073 | 10,073 | - | 0 | Common Stock | |
| Martin J. Bonick | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2025 | 134,927 | 1,126,984 | - | 0 | Common Stock | |
| Alfred Lumsdaine | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 13.75 per share. | 31 Mar 2025 | 2,510 | 160,565 | - | 13.8 | 34,513 | Common Stock |
| Alfred Lumsdaine | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2025 | 53,971 | 214,536 | - | 0 | Common Stock | |
| Martin J. Bonick | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 13.75 per share. | 31 Mar 2025 | 12,970 | 992,057 | - | 13.8 | 178,338 | Common Stock |
| Stephen C. Petrovich | EVP, GC and Asst. Secretary | Payment of exercise price or tax liability using portion of securities received from the company at price $ 13.75 per share. | 31 Mar 2025 | 1,428 | 696,828 | - | 13.8 | 19,635 | Common Stock |
| Stephen C. Petrovich | EVP, GC and Asst. Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2025 | 22,263 | 719,091 | - | 0 | Common Stock | |
| David Schultz | President Hospital Operations | 31 Mar 2025 | 26,985 | 64,172 | - | 0 | Common Stock | ||
| David Schultz | President Hospital Operations | 31 Mar 2025 | 1,825 | 37,187 | - | 13.8 | 25,094 | Common Stock | |
| Ethan Chernin | President of Health Services | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2025 | 20,914 | 35,988 | - | 0 | Common Stock | |
| Ethan Chernin | President of Health Services | Payment of exercise price or tax liability using portion of securities received from the company at price $ 13.75 per share. | 31 Mar 2025 | 1,332 | 15,074 | - | 13.8 | 18,315 | Common Stock |
| David Byers | SVP & Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2025 | 11,565 | 112,315 | - | 0 | Common Stock | |
| David Byers | SVP & Chief Accounting Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 13.75 per share. | 31 Mar 2025 | 676 | 100,750 | - | 13.8 | 9,295 | Common Stock |
| Rahul Sen | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Mar 2025 | 12,916 | 24,478 | - | 0 | Common Stock | |
| Edmondo Robinson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Mar 2025 | 12,916 | 43,984 | - | 0 | Common Stock | |
| Suzanne Campion | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Mar 2025 | 12,916 | 43,984 | - | 0 | Common Stock | |
| Robert Thomas Webb | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Mar 2025 | 12,916 | 63,984 | - | 0 | Common Stock | |
| William M. Goodyear | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Mar 2025 | 12,916 | 101,136 | - | 0 | Common Stock | |
| Peter C.B. Bynoe | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Mar 2025 | 12,916 | 101,136 | - | 0 | Common Stock | |
| Mark R. Sotir | Director, Chair of the Board | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Mar 2025 | 12,916 | 24,478 | - | 0 | Common Stock | |
| Suzanne Campion | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Dec 2024 | 10,793 | 31,068 | - | 0 | Common Stock | |
| Edmondo Robinson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Dec 2024 | 10,793 | 31,068 | - | 0 | Common Stock | |
| Robert Thomas Webb | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Dec 2024 | 10,793 | 51,068 | - | 0 | Common Stock | |
| William M. Goodyear | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Dec 2024 | 10,793 | 88,220 | - | 0 | Common Stock | |
| Peter C.B. Bynoe | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Dec 2024 | 10,793 | 88,220 | - | 0 | Common Stock | |
| Robert Thomas Webb | Director | Purchase of securities on an exchange or from another person at price $ 17.47 per share. | 08 Nov 2024 | 10,000 | 30,275 | - | 17.5 | 174,700 | Common Stock |
| Robert Thomas Webb | Director | Purchase of securities on an exchange or from another person at price $ 16.49 per share. | 08 Nov 2024 | 10,000 | 40,275 | - | 16.5 | 164,900 | Common Stock |
| David Byers | SVP & Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Sep 2024 | 6,447 | 101,426 | - | 0 | Common Stock | |
| David Schultz | See Remarks | 25 Sep 2024 | 16,535 | 39,012 | - | 0 | Common Stock | ||
| Stephen C. Petrovich | EVP, GC and Asst. Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Sep 2024 | 9,699 | 698,256 | - | 0 | Common Stock | |
| Alfred Lumsdaine | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Sep 2024 | 41,742 | 163,075 | - | 0 | Common Stock | |
| Mark R. Sotir | Director, Chair of the Board | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jul 2024 | 11,562 | 11,562 | - | 0 | Common Stock | |
| Alfred Lumsdaine | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jul 2024 | 30,922 | 121,333 | - | 0 | Common Stock | |
| Peter C.B. Bynoe | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jul 2024 | 11,562 | 77,427 | - | 0 | Common Stock | |
| William M. Goodyear | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jul 2024 | 11,562 | 77,427 | - | 0 | Common Stock | |
| Martin J. Bonick | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jul 2024 | 98,881 | 1,005,027 | - | 0 | Common Stock | |
| Robert Thomas Webb | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jul 2024 | 11,562 | 20,275 | - | 0 | Common Stock | |
| Stephen C. Petrovich | Executive VP, GC and Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jul 2024 | 17,584 | 688,557 | - | 0 | Common Stock | |
| David Schultz | See Remarks | 18 Jul 2024 | 22,477 | 22,477 | - | 0 | Common Stock | ||
| Ethan Chernin | President of Health Services | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jul 2024 | 16,406 | 16,406 | - | 0 | Common Stock | |
| David Byers | SVP & Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jul 2024 | 8,329 | 94,979 | - | 0 | Common Stock | |
| Suzanne Campion | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jul 2024 | 11,562 | 20,275 | - | 0 | Common Stock | |
| Edmondo Robinson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jul 2024 | 11,562 | 20,275 | - | 0 | Common Stock | |
| Rahul Sen | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jul 2024 | 11,562 | 11,562 | - | 0 | Common Stock |